Interferon beta-1a (Merck Serono)

干扰素β-1a (Merck Serono)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1a (Merck Serono)
Drug Alias Name倍他干扰素-1a (Merck Serono)Recombinant human interferon beta-1a (Merck Serono)重组人干扰素β1aRebif Rebidose (Merck Serono)IFN-beta1a (Merck Serono) +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeuritisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis +[4] 
Global Approved IndicationsMultiple Sclerosis
Approved Indications in ChinaMultiple Sclerosis
Original Approved Country/TerritoryEU
Original Approved Date1998/05/03
Country/TerritoryCzechiaBelgiumBulgaria +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono IncMerck Europe BvMerck Serono
Inactive CompaniesAzidus BrasilMerck KGaA, Darmstadt, GermanyMerck Serono International Sa
Active IndicationsMultiple Sclerosis
Inactive IndicationsNeuritisMultiple Sclerosis, Relapsing-RemittingColitis, Ulcerative

Other Information

ATC CodeL03AB07
Related LinksWikipediaDrugBankKEGG